Highlights Merck KGaA

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra Other stock markets 16:35:25 22/04/2026 BST			5-day change	1st Jan Change
115.60 ^EUR	-1.62%		-0.82%	-5.71%

04-22	Top Midday Stories: GE Vernova Shares Gain on Strong Q1 Earnings, Guidance; Vertiv Lifts Guidance After Q1 EPS, Revenue Beats, Shares Fall	MT
04-22	Merck, Rivals Show Interest in Inhibrx's Experimental Cancer Drug	MT

Highlights

04-22	Top Midday Stories: GE Vernova Shares Gain on Strong Q1 Earnings, Guidance; Vertiv Lifts Guidance After Q1 EPS, Revenue Beats, Shares Fall	MT
04-22	Merck, Rivals Show Interest in Inhibrx's Experimental Cancer Drug	MT
04-22	Merck, Rivals Show Interest in Inhibrx's Experimental Cancer Drug	MT
04-22	Merck, rivals eye Inhibrx experimental cancer drug tied to Keytruda, sources say	RE
04-20	Deals of the day-Mergers and acquisitions	RE
04-16	Merck KGaA Price Target, Forecasts Cut as AlphaValue/Baader Europe Notes 'Restrained' Growth Prospects	MT
04-16	Merck: Pharma business’s reinvigoration remains key for re-rating
04-08	AlphaValue/Baader Europe Lowers Target Price, Estimates for Sanofi Amid R&D Setbacks	MT
04-01	Germany's DAX Index Surges; Merck KGaA Shares Up	MT
04-01	Merck KGaA Completes Purchase of JSR Life Sciences' Chromatography Unit	MT
03-25	Pay rise for 585,000 workers in the chemical and pharmaceutical sectors	DP
03-24	Collective bargaining for chemical industry enters critical phase	DP
03-05	German Shares Slip; DHL Group Down on Cautious Outlook	MT
03-05	Merck: Q4 miss and slightly weak 2026 guidance
03-05	Merck KGaA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
03-05	Merck Outlook Disappoints – MS Drug Patent Loss Weighs on Forecast	RE
03-05	Merck Shares Under Pressure – UBS: Forecast Is Confusing	DP
03-05	UBS Maintains 'Buy' Rating on Merck KGaA — Target Price Set at €150	DP
03-05	Merck KGaA Proposes Dividend	CI
03-05	Merck KGaA Provides Earnings Guidance for the Year 2026	CI
03-05	Patent Loss for Blockbuster Drug Pressures Merck Forecast	RE
03-05	Merck KGaA sees earnings drop on currency effects, MS drug	RE
03-05	Germany's Merck KGaA Logs Lower FY25 Profit, Net Sales	MT
03-05	Germany's Merck KGaA Expects Currency Headwinds to Weigh on Earnings	DJ
03-05	Merck KGaA sees earnings decline of up to 4%	RE